Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma A/S to Expand Commercialization of Its Endocrinology Portfolio to Eurasian Markets
December 10, 2024 07:00 ET
|
Er-Kim
Er-Kim broadens drug distribution for novel rare endocrinology disease therapies in CEE and Eurasian markets
Automatic Immunoassay Analyzer Market to Reach $51.4 Billion, Globally, by 2033 at 15.3% CAGR: Allied Market Research
September 19, 2024 06:41 ET
|
Allied Analytics LLP
Wilmington, Delaware, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Automatic Immunoassay Analyzer Market by Product (Immunofluorescence, Chemiluminescence,...
YPrime Research Reveals User-Centric eCOA Technologies as Key to Overcoming Challenges in Endocrinology Clinical Trials
June 25, 2024 08:00 ET
|
Y-Prime, LLC
New YPrime research report sheds light on how technology can help solve challenges in endocrinology clinical trials.
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024 07:05 ET
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Er-Kim Announces Exclusive Distribution Agreement with Ascendis Pharma A/S to Commercialize 3 Endocrinology Disease Treatments Across Central & Eastern Europe and Turkey
January 08, 2024 18:01 ET
|
Er-Kim
Er-Kim is appointed as the exclusive Ascendis A/S endocrinology distributor across Central & Eastern Europe and Turkey
Immunoassay Market Set to Surge at 5.0% CAGR, to Reach USD 48.7 billion by 2031 | Transparency Market Research, Inc.
January 04, 2024 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The immunoassay market was valued at US$ 31.5 billion in 2022. A CAGR of 5.0% is expected...
Living with diabetes for decades
December 05, 2023 08:00 ET
|
Norton Healthcare
LOUISVILLE, Ky., Dec. 05, 2023 (GLOBE NEWSWIRE) -- In her new book, “Diabetes and Me: Living a Healthy and Empowered Life in the Face of Diabetes” (ISBN-13 9781633310803, Nov. 14, 2023),...
Home Infusion Therapy Market Size to Hit 8.6% CAGR with Infusion Pumps Segment Driving Growth During 2022–2028 | The Insight Partners
October 24, 2023 14:46 ET
|
The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed...
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Medicine Program
October 16, 2023 11:00 ET
|
Castle Connolly Private Health Partners
Dr. Christopher Fox and N.P. Sarah Sato Collaborate with Castle Connolly Private Health Partners to Create The Alpine Center CCPHP Concierge Program
Marius Pharmaceuticals Expands Access of KYZATREX™ (testosterone undecanoate) to Department of Veterans Affairs (VA), Pledging Support for Proper Hormonal Balance Among Military Personnel
September 19, 2023 09:30 ET
|
Marius Pharmaceuticals LLC
RALEIGH, N.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, is proud to announce the...